Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion type Assertion NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_head.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion wasGeneratedBy ECO_0000203 NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_provenance.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion wasDerivedFrom befree-20140225 NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_provenance.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion SIO_000772 7478581 NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_provenance.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion evidence source_evidence_literature NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_provenance.
- NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_assertion description "[Furthermore, VEGF overexpression occurs in 5/5 highly malignant anaplastic carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626478.RAzLn1MvLfpiOlci9VWyN7ijlzFeDfcziJntBeAygsCWU130_provenance.